InvestLog
HURA TuHURA Biosciences, Inc. logo

HURA TuHURA Biosciences, Inc.

Healthcare
$2.46+0.00%OpenMarket Cap: $156.3M

As of 2026-05-26

Valuation

View Details

P/E (TTM)

—

PEG

—

P/B

6.47

P/S

0.00

EV/EBITDA

-5.08

DCF Value

$0.07

FCF Yield

-17.2%

Div Yield

0.0%

Margins & Returns

Gross Margin

0.0%

Operating Margin

0.0%

Net Margin

0.0%

ROE

-154.0%

ROA

-104.1%

ROIC

-135.5%

Financials

View All
PeriodRevenueNet IncomeEPS
Q1 null$0.00$-7.5M$—
Q4 null$0.00$-6.8M$—
FY null$0.00$-30.1M$—
Q3 null$0.00$-7.1M$—

Analyst Ratings

View All

Consensus

Buy

Target (Consensus)

$—

Target (Median)

$—

Target Range

$— - $—

2 Strong Buy2 Buy0 Hold0 Sell0 Strong Sell
HC Wainwright & Co.Buy
2026-02-03
Maxim GroupBuy
2025-11-14

Trading Activity

Insider Trades

View All
Tendler Craigdirector
SellTue Feb 17
Ng George Kdirector
SellTue Feb 17
MANUSO JAMES S Jdirector
SellTue Feb 17
List Alandirector
SellTue Feb 17
Hoffman Robert E.director
SellTue Feb 17

Company Info

Sector

Healthcare

Industry

Biotechnology

Country

US

Exchange

—

Beta

-0.01

TuHURA Biosciences, Inc. is a phase 3 registration-stage immuno-oncology company developing novel technologies to overcome resistance to cancer immunotherapy. The company is headquartered in Tampa, FL.

Peers

ABOS logoABOSAGEN logoAGENCGTX logoCGTXINO logoINOIRD logoIRDMCRB logoMCRBSEER logoSEERSPRO logoSPROTVGN logoTVGNVTGN logoVTGN